Bo Peng
- Topics
- RNA modifications and cancer (12 papers)Cancer Immunotherapy and Biomarkers (9 papers)Microbial Natural Products and Biosynthesis (9 papers)
- Journals
- Journal of the American Chemical SocietyJournal of Biological ChemistryAngewandte Chemie International Edition
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Bo Peng
87 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Molecular Biology 645
- Oncology 362
- Pulmonary and Respiratory Medicine 181
- Immunology 146
- Organic Chemistry 145
Countries citing papers authored by Bo Peng
This map shows the geographic impact of Bo Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Peng more than expected).
Fields of papers citing papers by Bo Peng
This network shows the impact of papers produced by Bo Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Peng. The network helps show where Bo Peng may publish in the future.
Co-authorship network of co-authors of Bo Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Bo Peng. A scholar is included among the top collaborators of Bo Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Peng. Bo Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 6 | |
| 6 | 1 | |
| 7 | 13 | |
| 8 | 17 | |
| 9 | 4 | |
| 10 | 59 | |
| 11 | 11 | |
| 12 | 3 | |
| 13 | 3 | |
| 14 | 29 | |
| 15 | 49 | |
| 16 | 11 | |
| 17 | 109 | |
| 18 | 21 | |
| 19 | 68 | |
| 20 | 15 |
About Bo Peng
Bo Peng is a scholar working on Oncology, Pharmacology and Biotechnology, having authored 89 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (12 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Microbial Natural Products and Biosynthesis (9 papers). The work is most often cited by research in Oncology (362 citations), Molecular Biology (645 citations) and Cancer Research (130 citations). Bo Peng has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Shao Q. Yao, Shubo Du, Jinmin Liu, Yuchen Tang, Bin Geng, Linghui Qian, Xin Mao, Johan Y. Y. Ng, Amy S. Ha and Zhongcheng Liu. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.